Mumbai, India , is rapidly emerging as a vital hub for the creation of Lenacapavir Sodium API (CAS 2189684-53-3). Several companies have established strong manufacturing units focusing on this essential antiviral drug . Identifying the absolute top manufacturers can be complex due to fluctuating